COVID-19 vaccines
COVID-19 vaccines
Unlocking Biomanufacturing: Break Up Virus-Like Particles!
Unlocking biomanufacturing potential! 🌱 Breaking virus-like particles boosts efficiency, enhances yield, and promises innovative applications for vaccines! 🚀💡
Revolutionizing mRNA: A Breakthrough in Biologics!
🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡
Revolutionizing Vaccine Production: Tech Meets Efficiency!
Discover how digital technologies are transforming vaccine manufacturing! 🌟 Automation in fermentation boosts efficiency and accelerates development. 🚀🔬 Vaccines Innovation
Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!
📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍
French Company Receives $6m Grant to Fight Malaria
📢 French company Medincell Corp awarded $6m grant by Unitaid to fund safety testing of its malaria vaccine mdc-STM. 🌍🦟
The High Costs of Low-Quality Albumin: Risks and Solutions
1. 🚫💉 The Hidden Costs of Sub-standard Recombinant Albumin: Lost batches and patient risks in vaccines and biopharmaceuticals. 💰💊 2. The Hidden Costs of Sub-standard Recombinant Albumin: Safely lowering prices and broadening access to premium albumin. 💡💉🌾🔬🔍
WHO Launches Biomanufacturing Training to Boost Global Vaccine Production
🌍 WHO launches Biomanufacturing Workforce Training Initiative to improve bioproduction in LMICs. 🏭💪🔬 Enhancing local vaccine production and building capacity.
Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient
🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.
Revolutionary Method Purifies Virus-Like Particles Easily!
🔬 Malaysian researchers purify virus-like particles (VLPs) without chromatography columns using metal ions, simplifying vaccine production. 💉🌡️🧪💭
Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines
🔬 GSK teams up with Elegen Bio to develop DNA-based medicines and vaccines, revolutionizing the field of biotechnology. 💉💊
